AK

Alok Kashyap

Active Director Director DIN 08673732
DIN 08673732 First appointment Jan 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Alok Kashyap

Data last updated:

Alok Kashyap is a Director at Biobery Lifesciences Private Limited (since 2020). The company operates in Pharma.

DIN 08673732
Primary Designation Director
Industry Pharma
First Appointment 21 Jan 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biobery Lifesciences Private Limited U24304UP2020PTC125945
Director21 Jan 20202020Active

Directorship timeline

Open interactive timeline →
Biobery Lifesciences Private Limited
Premium access

Shareholding and investment profile for Alok Kashyap

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alok Kashyap

Alok Kashyap currently holds 1 directorship: Biobery Lifesciences Private Limited (Director, since 21 Jan 2020).

Alok Kashyap was first appointed on 21 Jan 2020 as Director at Biobery Lifesciences Private Limited.

The current boards of Alok Kashyap's companies include Devendra Kumar Upadhyay (Biobery Lifesciences Private Limited), Jyoti Prasad (Biobery Lifesciences Private Limited), Narayan Dutt Tiwari (Biobery Lifesciences Private Limited), Saurabh Sawhney (Biobery Lifesciences Private Limited), Shri Bhagwan Sharma (Biobery Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available